全球皮膚切片檢查市場

預計到 2030 年全球皮膚切片檢查市場規模將達到 1.492 億美元

2024 年全球皮膚切片檢查市場規模估計為 1.169 億美元，預計到 2030 年將達到 1.492 億美元，在 2024-2030 年分析期內的複合年成長率為 4.1%。刮除活體組織切片是報告中分析的細分領域之一，預計其複合年成長率為 3.2%，到分析期結束時將達到 7540 萬美元。在分析期內，穿刺切片檢查部分的成長率估計為 5.3%。

美國市場規模估計為 3,190 萬美元，中國市場預計複合年成長率為 7.4%

預計 2024 年美國皮膚切片檢查市場價值將達到 3,190 萬美元。作為世界第二大經濟體，中國預計到 2030 年市場規模將達到 3,020 萬美元，2024 年至 2030 年的複合年成長率為 7.4%。其他值得注意的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為 1.8% 和 3.2%。在歐洲，德國的複合年成長率預計為 2.4%。

全球「皮膚切片檢查」市場—主要趨勢和促進因素摘要

為什麼皮膚切片檢查成為皮膚病治療的診斷基石？

皮膚切片檢查為了解多種皮膚病（從良性腫瘤和發炎性疾病到自體免疫疾病和各種皮膚癌）提供了重要的見解，鞏固了其作為現代皮膚病學關鍵診斷技術的地位。這可以透過多種方法來完成，包括刮取切片檢查、穿刺切片檢查、切除活體組織切片和切開切片檢查，以收集皮膚組織進行組織病理學分析。切片檢查是一種微創、快速且門診的手術，使其實用且易於臨床醫生接受。全球皮膚癌（尤其是黑色素瘤、基底細胞癌和鱗狀細胞癌）的發生率不斷上升，使得早期準確的切片檢查診斷成為醫學上的必要。此外，乾癬、濕疹、紅斑狼瘡和扁平苔癬等慢性皮膚病通常需要切片檢查確認以調整治療。在精準醫療時代，切片檢查不僅可以用於診斷，還可以用於預後，從而實現生物標記的發現、基因分析和免疫組織化學分析。真菌性皮膚病、麻風病、皮膚結核病等感染疾病在流行地區也需要進行皮膚切片檢查。它的效用超越了疾病類型、年齡層和醫療保健環境，皮膚切片檢查對於及時和明確的皮膚病診斷和治療計劃至關重要。

科技進步如何提高皮膚切片檢查程序的準確性和效率？

最近的技術創新已將皮膚切片檢查從手動、視覺引導程序轉變為數據豐富的診斷過程。高解析度皮膚鏡和數位成像系統使皮膚科醫生能夠在進行切片檢查之前更準確地識別可疑病變。機器人輔助穿刺切片檢查工具和整合切片皮膚掃描儀提高了程序的一致性並減少了組織損傷。組織病理學工作流程也正在透過數位病理學平台進行升級，該平台使用人工智慧和機器學習來掃描、分類和解釋組織樣本，使其更加準確和快速。全幻燈片成像，加上雲端基礎的資料共用，可以實現對複雜病例的遠端諮詢和第二意見。另一方面，諸如黏性貼片切片檢查（例如膠帶剝離）等微創技術已引起人們的關注，尤其是在小兒科和美容皮膚科領域，因為它們可以無痛地收集表層細胞。目前，分子診斷檢測和基因組定序已在切片檢查樣本上進行常規研究，揭示突變和免疫特徵，有助於個人化治療，特別是黑色素瘤和罕見的皮膚淋巴瘤。透過一次性無菌器械、內建麻醉劑和快速固定劑，切片檢查套件的自動化簡化了臨床程序。這些進步不僅提高了診斷產量比率，也提高了患者的安全性、滿意度和治療效果。

皮膚切片檢查在臨床和公共衛生環境中發揮什麼作用？

皮膚切片檢查在世界各地的皮膚病診所、腫瘤中心、病理實驗室、學術機構和公共衛生計畫中發揮著至關重要的作用。在先進的醫療保健系統中，切片檢查是皮膚病理學工作流程中不可或缺的一部分，並指南皮膚癌和自體免疫疾病的治療決策。在腫瘤學中，切片檢查對於腫瘤分期、評估手術邊緣和評估治療結果至關重要。在免疫皮膚病學中，我們支持複雜水痘疾病、血管炎和結締組織疾病的診斷。兒科皮膚科醫生使用切片檢查來區分兒童良性皮疹和早發性遺傳綜合症。在貧困和偏遠地區，配備切片檢查套件包的流動皮膚病科有助於篩檢和診斷被忽視的熱帶疾病，如利利什曼原蟲症和足菌腫。公共皮膚癌篩檢宣傳活動通常結合切片檢查功能，以提供當天的診斷和分類。切片檢查在新的皮膚病治療的臨床試驗中也發揮著重要作用，可作為療效的基準和治療後基準。此外，皮膚切片檢查是學術和藥物研究的基礎，為新生物製藥、局部治療藥物和疫苗的開發提供資訊。從早期檢測到精準腫瘤學再到治療研究，其跨領域重要性凸顯了其在現代醫療保健生態系統中的重要角色。

皮膚切片檢查市場的成長受到多種因素的推動，這些因素反映了皮膚病的趨勢、技術整合以及醫療保健管道的擴大。

成長要素是，由於人口老化、紫外線照射增加和生活方式的改變，全球皮膚癌（尤其是黑色素瘤）的發生率不斷增加。隨著人們意識的增強和積極的皮膚健康行為，皮膚科服務也同步成長，導致臨床和美容皮膚切片檢查數量增加。技術整合，特別是數位病理學、人工智慧輔助診斷和分子分析，正在擴大切片檢查效用範圍和效率，鼓勵在整個醫療保健領域更廣泛地採用。此外，門診和流動皮膚病學服務的普及使得切片檢查變得更加容易，從而刺激了醫院外該程序的發展。自體免疫和發炎性皮膚病的快速增加，尤其是在年輕人和由於環境壓力而導致的人群中，進一步增加了對組織病理學確認的需求。新興國家不斷成長的醫療支出和基礎設施，加上減少未確診癌症和被忽視的皮膚病負擔的努力，正在推動亞太、拉丁美洲和非洲的市場成長。同時，監管部門對新切片檢查工具和非侵入性採樣技術的核准正在使產品系列多樣化並減少程序障礙。疾病流行、診斷創新、醫療保健分散化和全球准入等相互交叉的趨勢正在推動皮膚切片檢查市場的強勁和持續成長。

部分

類型（刮取切片檢查、穿刺切片檢查、切開切片檢查）、適應症（皮膚癌、光化性角化病、皮膚炎、其他適應症）、最終用戶（醫院和診所、診斷實驗室、其他最終用戶）

受訪企業範例（共34家）

• AccuTec Blades Inc.
• Acuderm Inc.
• Becton, Dickinson and Company
• Biodesix
• Biomarker Technologies
• Boston Scientific Corporation
• Cardinal Health
• Cook Medical
• Danaher Corporation
• DTR Medical Ltd
• Exact Sciences Corporation
• Freenome Holdings, Inc.
• Gallini Srl
• GenMark Diagnostics
• GRAIL, Inc.
• Hologic, Inc.
• Innovia Medical
• Integra LifeSciences
• Leica Biosystems
• Vernacare

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地以及進出口（成品和OEM）預測公司競爭地位的變化。這種複雜且多方面的市場動態預計將以多種方式影響競爭對手，包括人為提高銷貨成本、降低盈利、重組供應鏈等微觀和宏觀市場動態。

全球產業分析師密切關注世界領先的首席經濟學家（14,949）、智庫（62）和貿易及產業協會（171）的專家意見，以評估生態系統的影響並應對新的市場現實。各主要國家的專家和經濟學家都在關注關稅及其對國家的影響。

全球產業分析師預計，這種動盪將在未來幾個月內平息，新的世界秩序將更加明確地建立。全球產業分析師正在即時追蹤這些發展。

2025年4月：談判階段

我們四月份的發布將涵蓋關稅對全球市場整體的影響，並為各地區的市場調整提供指導。我們的預測是基於歷史數據和不斷發展的市場影響因素。

2025年7月：最終關稅調整

在各國宣布最終重置後，客戶將於 7 月收到免費更新。最終更新包含明確的關稅影響分析。

相互和雙邊貿易及關稅影響分析：

美國<>中國<>墨西哥<>加拿大<>歐盟<>日本<>印度<>其他176個國家

領先的產業經濟學家：全球產業分析師知識庫追蹤 14,949 位經濟學家，其中包括來自民族國家、智庫、貿易和產業協會、大型企業和領域專家的最具影響力的首席經濟學家，他們共用了全球經濟狀況這一前所未有的模式轉移的影響。我們的 16,491 多份報告中的大多數都遵循這個基於兩階段里程碑的發布計劃。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 比賽

Global Skin Biopsy Market to Reach US$149.2 Million by 2030

The global market for Skin Biopsy estimated at US$116.9 Million in the year 2024, is expected to reach US$149.2 Million by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Shave Biopsy, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$75.4 Million by the end of the analysis period. Growth in the Punch Biopsy segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$31.9 Million While China is Forecast to Grow at 7.4% CAGR

The Skin Biopsy market in the U.S. is estimated at US$31.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$30.2 Million by the year 2030 trailing a CAGR of 7.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.

Global "Skin Biopsy" Market - Key Trends & Drivers Summarized

Why Has Skin Biopsy Become The Diagnostic Cornerstone Of Dermatological Care?

Skin biopsy has solidified its position as a primary diagnostic technique in modern dermatology, offering critical insights into a wide range of skin conditions, from benign growths and inflammatory disorders to autoimmune diseases and various forms of skin cancer. Performed using methods such as shave biopsy, punch biopsy, excisional biopsy, or incisional biopsy, the procedure allows for the extraction and histopathological analysis of skin tissue. It is minimally invasive, quick, and can be done in outpatient settings, making it a practical and accessible tool for clinicians. The rising global incidence of skin cancers-especially melanoma, basal cell carcinoma, and squamous cell carcinoma-has made early and accurate biopsy-driven diagnosis a medical necessity. Additionally, chronic dermatological conditions like psoriasis, eczema, lupus erythematosus, and lichen planus often require biopsy confirmation to tailor treatment. In the age of precision medicine, biopsies are not only diagnostic but also prognostic, enabling biomarker discovery, genetic analysis, and immunohistochemical profiling. Infections like fungal dermatoses, leprosy, and cutaneous tuberculosis also necessitate skin biopsies in endemic regions. With their utility spanning across disease types, age groups, and healthcare environments, skin biopsies are indispensable for timely, definitive dermatological diagnosis and treatment planning.

How Are Technological Advances Enhancing Accuracy And Efficiency In Skin Biopsy Procedures?

Recent technological innovations are transforming skin biopsy from a manual, visually guided procedure into a data-rich diagnostic process. High-resolution dermoscopy and digital imaging systems now allow dermatologists to identify suspicious lesions with greater precision before a biopsy is performed. Robotics-assisted punch biopsy tools and microtome-integrated skin scanners are improving procedural consistency and reducing tissue damage. Histopathology workflows have also been upgraded through digital pathology platforms that use AI and machine learning to scan, classify, and interpret tissue samples with enhanced accuracy and speed. Whole-slide imaging, coupled with cloud-based data sharing, allows for remote consultations and second opinions in complex cases. Meanwhile, minimally invasive techniques such as adhesive patch biopsies (e.g., tape stripping) are gaining attention for their ability to collect superficial cells painlessly, especially in pediatric and cosmetic dermatology. Molecular diagnostic assays and genomic sequencing are now routinely conducted on biopsy samples, revealing mutations and immune signatures that inform personalized treatment-especially in melanomas and rare cutaneous lymphomas. Automation in biopsy kits, including single-use sterilized instruments, built-in anesthetics, and rapid fixation solutions, is streamlining in-clinic procedures. Together, these advancements are not only enhancing diagnostic yield but also improving patient safety, satisfaction, and outcomes.

Where Is Skin Biopsy Playing A Transformative Role Across Clinical And Public Health Sectors?

Skin biopsy is playing a pivotal role across dermatology clinics, oncology centers, pathology labs, academic institutions, and public health programs worldwide. In developed healthcare systems, biopsies are integral to dermatopathology workflows, guiding treatment decisions in skin cancers and autoimmune conditions. In oncology, biopsies are essential for staging tumors, evaluating surgical margins, and assessing treatment response. In immunodermatology, they support the diagnosis of complex blistering diseases, vasculitis, and connective tissue disorders. Pediatric dermatologists rely on biopsies to distinguish between benign pediatric rashes and early-onset genetic syndromes. In underserved and remote areas, mobile dermatology units equipped with biopsy kits are helping screen and diagnose neglected tropical diseases, including leishmaniasis and mycetoma. Public skin cancer screening campaigns often integrate biopsy capabilities to provide same-day diagnosis and triage. Biopsies also play a critical role in clinical trials for new dermatological therapies, serving as baseline and post-treatment benchmarks for efficacy. Furthermore, skin biopsies are foundational in academic and pharmaceutical research, aiding in the development of new biologics, topical treatments, and vaccines. Their cross-disciplinary importance-from early detection to precision oncology and therapeutic research-highlights their indispensable role in modern healthcare ecosystems.

The Growth In The Skin Biopsy Market Is Driven By Several Factors That Reflect Dermatological Disease Trends, Technological Integration, And Healthcare Accessibility Expansion

A significant growth driver is the global rise in skin cancer incidence, especially melanoma, driven by aging populations, increased UV exposure, and lifestyle changes. Parallel growth in dermatology services, driven by improved awareness and proactive skin health behaviors, has led to a higher volume of skin biopsies in both clinical and cosmetic settings. Technological integration-particularly digital pathology, AI-assisted diagnostics, and molecular analysis-has expanded the scope and efficiency of biopsy utility, encouraging broader adoption across healthcare tiers. Additionally, the growing availability of dermatology services in ambulatory and outpatient settings has made biopsies more accessible, fueling procedural growth even outside of hospitals. The surge in autoimmune and inflammatory skin disorders, especially among younger demographics and due to environmental stressors, further amplifies the need for histopathological confirmation. Increasing healthcare spending and infrastructure in emerging economies, combined with efforts to reduce the burden of undiagnosed cancers and neglected skin conditions, are driving market growth in Asia-Pacific, Latin America, and Africa. Meanwhile, regulatory approval of newer biopsy tools and non-invasive sampling techniques is diversifying product portfolios and reducing procedural barriers. These intersecting trends-disease prevalence, diagnostic innovation, healthcare decentralization, and global access-are powering the strong, sustained expansion of the skin biopsy market.

SCOPE OF STUDY:

The report analyzes the Skin Biopsy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Shave Biopsy, Punch Biopsy, Excisional Biopsy); Indication (Skin Cancer, Actinic Keratosis, Dermatitis, Other Indications); End-Use (Hospitals & Clinics, Diagnostic Laboratories, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• AccuTec Blades Inc.
• Acuderm Inc.
• Becton, Dickinson and Company
• Biodesix
• Biomarker Technologies
• Boston Scientific Corporation
• Cardinal Health
• Cook Medical
• Danaher Corporation
• DTR Medical Ltd
• Exact Sciences Corporation
• Freenome Holdings, Inc.
• Gallini Srl
• GenMark Diagnostics
• GRAIL, Inc.
• Hologic, Inc.
• Innovia Medical
• Integra LifeSciences
• Leica Biosystems
• Vernacare

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Skin Biopsy - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Skin Cancer and Chronic Dermatological Conditions Drives Biopsy Demand
  • Growing Awareness and Early Diagnosis Campaigns Propel Skin Biopsy Procedure Volume
  • Advancements in Minimally Invasive Biopsy Devices Improve Patient Acceptance and Outcomes
  • Increased Adoption of Teledermatology and AI Diagnostics Strengthens Screening Rates
  • Integration of Biopsy Services into Primary Care Clinics Expands Patient Access
  • Dermatology-Focused Clinical Trials and R&D Stimulate Market for Diagnostic Biopsies
  • Regulatory Approvals for New Biopsy Tools Accelerate Technology Penetration
  • Rising Demand for Histopathological Analysis in Aesthetic Dermatology Expands Market Scope
  • Expansion of Skin Biopsy Use in Personalized Medicine Drives Precision Diagnostics
  • Aging Population with Higher Incidence of Skin Disorders Sustains Long-Term Demand
  • Rapid Growth in Outpatient Dermatology Centers Spurs Procedural Volume
  • Health Insurance Coverage Expansion in Emerging Markets Improves Accessibility to Biopsy Services
  • Technological Improvements in Imaging-Guided Biopsies Enhance Diagnostic Accuracy
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Skin Biopsy Market Analysis of Annual Sales in US$ for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Skin Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Skin Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Skin Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Shave Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Shave Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Shave Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Punch Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Punch Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Punch Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Excisional Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Excisional Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Excisional Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Skin Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Skin Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Skin Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Actinic Keratosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Actinic Keratosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Actinic Keratosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Dermatitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Dermatitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Dermatitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• JAPAN
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• CHINA
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 62: China Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• EUROPE
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Skin Biopsy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Skin Biopsy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Skin Biopsy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• FRANCE
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 83: France Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• GERMANY
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 110: UK Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Skin Biopsy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Skin Biopsy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Skin Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• INDIA
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 167: India Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Skin Biopsy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Skin Biopsy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Skin Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Skin Biopsy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Skin Biopsy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Skin Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030
• AFRICA
  • Skin Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Skin Biopsy by Type - Shave Biopsy, Punch Biopsy and Excisional Biopsy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Skin Biopsy by Type - Percentage Breakdown of Value Sales for Shave Biopsy, Punch Biopsy and Excisional Biopsy for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Skin Biopsy by End-Use - Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Skin Biopsy by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals & Clinics and Diagnostic Laboratories for the Years 2015, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Skin Biopsy by Indication - Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Skin Biopsy by Indication - Percentage Breakdown of Value Sales for Skin Cancer, Actinic Keratosis, Dermatitis and Other Indications for the Years 2015, 2025 & 2030

IV. COMPETITION